Literature DB >> 9316769

Autoimmune reactivity in inflammatory bowel disease.

D F Keren1, J A Goeken.   

Abstract

Inflammatory bowel disease remains a poorly understood chronic inflammatory condition of the bowel. No etiologic agents, or agreed upon pathogenesis is currently known. Recent findings that perinuclear antineutrophil cytoplasmic antibodies (P-ANCA) are present in the vast majority of patients with this disease have proven to be of use in epidemiologic studies. Its clinical use is currently being explored by several investigators.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9316769

Source DB:  PubMed          Journal:  Clin Lab Med        ISSN: 0272-2712            Impact factor:   1.935


  1 in total

1.  Prevalence of macrocreatinkinase type 1 in patients with inflammatory bowel disease.

Authors:  J L Perez-Calle; I Marin-Jimenez; P Lopez-Serrano; J P Gisbert; A S Pena; C Fernandez-Rodriguez
Journal:  Dig Dis Sci       Date:  2007-06-28       Impact factor: 3.199

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.